{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:45:24Z","timestamp":1793961924065,"version":"4.8.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-18547-0","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:33:50Z","timestamp":1758886430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["In silico approaches unveil the mechanism of action of Eclipta prostrata against acute myeloid leukemia"],"prefix":"10.1038","volume":"15","author":[{"given":"K.M. Tanjida","family":"Islam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Muzahidul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisan Bin","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susen","family":"Sarker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azrin","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md","family":"Sohel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahmida","family":"Tabassum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saborni","family":"Sarker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheikh Abdullah","family":"Al Ashik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roksana","family":"Khanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"18547_CR1","doi-asserted-by":"crossref","unstructured":"Newell, L. F. & Cook, R. J. Advances in acute myeloid leukemia. Bmj 375, (2021).","DOI":"10.1136\/bmj.n2026"},{"key":"18547_CR2","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajh.26822","volume":"98","author":"S Shimony","year":"2023","unstructured":"Shimony, S., Stahl, M. & Stone, R. M. Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am. J. Hematol. 98, 502\u2013526 (2023).","journal-title":"Am. J. Hematol."},{"key":"18547_CR3","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1002\/cncr.22976","volume":"110","author":"R Baz","year":"2007","unstructured":"Baz, R. et al. Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia. Cancer 110, 1752\u20131759 (2007).","journal-title":"Cancer"},{"key":"18547_CR4","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1056\/NEJM199909303411407","volume":"341","author":"B Lowenberg","year":"1999","unstructured":"Lowenberg, B., Downing, J. R. & Burnett, A. Acute myeloid leukemia. N. Engl. J. Med. 341, 1051\u20131062 (1999).","journal-title":"N. Engl. J. Med."},{"key":"18547_CR5","first-page":"3323","volume":"89","author":"CP Leith","year":"1997","unstructured":"Leith, C. P. et al. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest oncology group study. Blood, J. Am. Soc. Hematol. 89, 3323\u20133329 (1997).","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"18547_CR6","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3324\/haematol.2018.208637","volume":"105","author":"C Talati","year":"2020","unstructured":"Talati, C. et al. Comparisons of commonly used front-line regimens on survival outcomes in patients aged 70 years and older with acute myeloid leukemia. Haematologica 105, 398 (2020).","journal-title":"Haematologica"},{"key":"18547_CR7","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H D\u00f6hner","year":"2015","unstructured":"D\u00f6hner, H., Weisdorf, D. J. & Bloomfield, C. D. Acute myeloid leukemia. N. Engl. J. Med. 373, 1136\u20131152 (2015).","journal-title":"N. Engl. J. Med."},{"key":"18547_CR8","first-page":"453","volume":"115","author":"H D\u00f6hner","year":"2010","unstructured":"D\u00f6hner, H. et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood, J. Am. Soc. Hematol. 115, 453\u2013474 (2010).","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"18547_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s40001-023-01060-3","volume":"28","author":"Y Gao","year":"2023","unstructured":"Gao, Y. et al. Analysis of the differential expression and prognostic relationship of DEGs in AML based on TCGA database. Eur. J. Med. Res. 28, 103 (2023).","journal-title":"Eur. J. Med. Res."},{"key":"18547_CR10","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/tox.22577","volume":"33","author":"M Liao","year":"2018","unstructured":"Liao, M. et al. Antimetastatic effects of Eclipta prostrata extract on oral cancer cells. Environ. Toxicol. 33, 923\u2013930 (2018).","journal-title":"Environ. Toxicol."},{"key":"18547_CR11","doi-asserted-by":"publisher","first-page":"155401","DOI":"10.1016\/j.phymed.2024.155401","volume":"128","author":"W Li","year":"2024","unstructured":"Li, W. et al. Ethanol extract of Eclipta prostrata induces multiple myeloma ferroptosis via Keap1\/Nrf2\/HO-1 axis. Phytomedicine 128, 155401 (2024).","journal-title":"Phytomedicine"},{"key":"18547_CR12","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1016\/j.fct.2012.08.007","volume":"50","author":"Q-M Liu","year":"2012","unstructured":"Liu, Q.-M., Zhao, H.-Y., Zhong, X.-K. & Jiang, J.-G. Eclipta prostrata L. phytochemicals: isolation, structure elucidation, and their antitumor activity. Food Chem. Toxicol. 50, 4016\u20134022 (2012).","journal-title":"Food Chem. Toxicol."},{"key":"18547_CR13","unstructured":"Osei-Safo, D., Amewu, R. K. & Sakyi, P. O. Synthetic and Naturally Occurring Heterocyclic Anticancer Compounds with Multiple Biological Targets. (2021)."},{"key":"18547_CR14","doi-asserted-by":"crossref","unstructured":"Sobolewska, I. P. K. G. D., Makowska-Was, D. W.-B. J. & Galanty, A. Saponins as cytotoxic agents: an update (2010\u20132021). Part II\u2014Triterpene saponins.","DOI":"10.1007\/s11101-020-09661-0"},{"key":"18547_CR15","doi-asserted-by":"publisher","first-page":"8827","DOI":"10.1021\/acsomega.3c00156","volume":"8","author":"RP Vivek-Ananth","year":"2023","unstructured":"Vivek-Ananth, R. P., Mohanraj, K., Sahoo, A. K. & Samal, A. IMPPAT 2.0: An enhanced and expanded phytochemical atlas of Indian medicinal plants. ACS Omega 8, 8827\u20138845 (2023).","journal-title":"ACS Omega"},{"key":"18547_CR16","doi-asserted-by":"publisher","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","volume":"47","author":"S Kim","year":"2019","unstructured":"Kim, S. et al. PubChem 2019 update: improved access to chemical data. Nucleic Acids Res. 47, D1102\u2013D1109 (2019).","journal-title":"Nucleic Acids Res."},{"key":"18547_CR17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1080\/02763869.2020.1826228","volume":"39","author":"J White","year":"2020","unstructured":"White, J. PubMed 2.0. Med. Ref. Serv. Q 39, 382\u2013387 (2020).","journal-title":"Med. Ref. Serv. Q"},{"key":"18547_CR18","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017).","journal-title":"Sci. Rep."},{"key":"18547_CR19","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires, D. E. V., Blundell, T. L. & Ascher, D. B. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 58, 4066\u20134072 (2015).","journal-title":"J. Med. Chem."},{"key":"18547_CR20","doi-asserted-by":"publisher","first-page":"9592","DOI":"10.1002\/chem.201001051","volume":"16","author":"Y Wu","year":"2010","unstructured":"Wu, Y. et al. Proaromaticity: organic charge-transfer chromophores with small HOMO\u2013LUMO Gaps. Chem.- A Eur. J. 16, 9592\u20139605 (2010).","journal-title":"Chem.- A Eur. J."},{"key":"18547_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1063\/1.4999761","volume":"147","author":"M Franco-P\u00e9rez","year":"2017","unstructured":"Franco-P\u00e9rez, M., Ayers, P. W., G\u00e1zquez, J. L. & Vela, A. Thermodynamic responses of electronic systems. J. Chem. Phys. 147, 9 (2017).","journal-title":"J. Chem. Phys."},{"key":"18547_CR22","doi-asserted-by":"publisher","first-page":"9430","DOI":"10.1021\/acs.jpca.3c04331","volume":"127","author":"LFA Ferr\u00e3o","year":"2023","unstructured":"Ferr\u00e3o, L. F. A. et al. Stability and Reactivity of the Phenalene and Olympicene Isomers. J. Phys. Chem. A 127, 9430\u20139441 (2023).","journal-title":"J. Phys. Chem. A"},{"key":"18547_CR23","doi-asserted-by":"publisher","first-page":"805","DOI":"10.13005\/ojc\/370406","volume":"37","author":"A Ehouman","year":"2021","unstructured":"Ehouman, A., Kouakou, A., Diarrassouba, F., Ouattara, H. A. A. & Niamien, P. M. Study of the stability and chemical reactivity of a series of tetrazole pyrimidine hybrids by the density functional theory method (DFT). Orient. J. Chem 37, 805\u2013812 (2021).","journal-title":"Orient. J. Chem"},{"key":"18547_CR24","unstructured":"Garc\u00eda-Valverde, M., Cordero, N. A. & de la Cal, E. S. GAUSSVIEW\u00ae as a tool for learning organic chemistry. in EDULEARN15 Proceedings 4366\u20134370 (IATED, 2015)."},{"key":"18547_CR25","doi-asserted-by":"publisher","first-page":"W32","DOI":"10.1093\/nar\/gku293","volume":"42","author":"D Gfeller","year":"2014","unstructured":"Gfeller, D. et al. SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic Acids Res. 42, W32\u2013W38 (2014).","journal-title":"Nucleic Acids Res."},{"key":"18547_CR26","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 47, W357\u2013W364 (2019).","journal-title":"Nucleic Acids Res."},{"key":"18547_CR27","doi-asserted-by":"publisher","first-page":"D1045","DOI":"10.1093\/nar\/gkv1072","volume":"44","author":"MK Gilson","year":"2016","unstructured":"Gilson, M. K. et al. BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res. 44, D1045\u2013D1053 (2016).","journal-title":"Nucleic Acids Res."},{"key":"18547_CR28","doi-asserted-by":"publisher","first-page":"23909","DOI":"10.1038\/s41598-021-03249-0","volume":"11","author":"W Wang","year":"2021","unstructured":"Wang, W. et al. The mining and construction of a knowledge base for gene-disease association in mitochondrial diseases. Sci. Rep. 11, 23909 (2021).","journal-title":"Sci. Rep."},{"key":"18547_CR29","doi-asserted-by":"publisher","first-page":"14256","DOI":"10.3390\/ijms232214256","volume":"23","author":"\u00c1 Alcal\u00e1-Santiago","year":"2022","unstructured":"Alcal\u00e1-Santiago, \u00c1. et al. Vitamin D deficiency and COVID-19: a biological database study on pathways and gene-disease associations. Int. J. Mol. Sci. 23, 14256 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"18547_CR30","doi-asserted-by":"publisher","first-page":"D877","DOI":"10.1093\/nar\/gkw1012","volume":"45","author":"N Rappaport","year":"2017","unstructured":"Rappaport, N. et al. MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search. Nucleic Acids Res. 45, D877\u2013D887 (2017).","journal-title":"Nucleic Acids Res."},{"key":"18547_CR31","first-page":"D845","volume":"48","author":"J Pi\u00f1ero","year":"2020","unstructured":"Pi\u00f1ero, J. et al. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res. 48, D845\u2013D855 (2020).","journal-title":"Nucleic Acids Res."},{"key":"18547_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12859-015-0611-3","volume":"16","author":"H Heberle","year":"2015","unstructured":"Heberle, H., Meirelles, G. V., da Silva, F. R., Telles, G. P. & Minghim, R. InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams. BMC Bioinform. 16, 1\u20137 (2015).","journal-title":"BMC Bioinform."},{"key":"18547_CR33","doi-asserted-by":"publisher","first-page":"bbab108","DOI":"10.1093\/bib\/bbab108","volume":"22","author":"A Jia","year":"2021","unstructured":"Jia, A., Xu, L. & Wang, Y. Venn diagrams in bioinformatics. Brief Bioinform. 22, bbab108 (2021).","journal-title":"Brief Bioinform."},{"key":"18547_CR34","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/lary.29025","volume":"131","author":"DY Lee","year":"2021","unstructured":"Lee, D. Y. et al. Actin-associated gene expression is associated with early regional metastasis of tongue cancer. Laryngoscope 131, 813\u2013819 (2021).","journal-title":"Laryngoscope"},{"key":"18547_CR35","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman, B. T. et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 50, W216\u2013W221 (2022).","journal-title":"Nucleic Acids Res."},{"key":"18547_CR36","doi-asserted-by":"publisher","first-page":"e0294236","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang, D. et al. SRplot: A free online platform for data visualization and graphing. PLoS ONE 18, e0294236 (2023).","journal-title":"PLoS ONE"},{"key":"18547_CR37","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge, S. X., Jung, D. & Yao, R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics 36, 2628\u20132629 (2020).","journal-title":"Bioinformatics"},{"key":"18547_CR38","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45, D353\u2013D361 (2017).","journal-title":"Nucleic Acids Res."},{"key":"18547_CR39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41392-020-00315-3","volume":"5","author":"H Lu","year":"2020","unstructured":"Lu, H. et al. Recent advances in the development of protein\u2013protein interactions modulators: mechanisms and clinical trials. Signal Transduct. Target Ther. 5, 213 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"18547_CR40","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51, D638\u2013D646 (2023).","journal-title":"Nucleic Acids Res."},{"key":"18547_CR41","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41597-021-01069-5","volume":"8","author":"F Meng","year":"2021","unstructured":"Meng, F., Xi, Y., Huang, J. & Ayers, P. W. A curated diverse molecular database of blood-brain barrier permeability with chemical descriptors. Sci. Data 8, 289 (2021).","journal-title":"Sci. Data"},{"key":"18547_CR42","doi-asserted-by":"publisher","first-page":"5101","DOI":"10.1016\/j.eswa.2013.03.027","volume":"40","author":"K McGarry","year":"2013","unstructured":"McGarry, K. Discovery of functional protein groups by clustering community links and integration of ontological knowledge. Expert Syst. Appl. 40, 5101\u20135112 (2013).","journal-title":"Expert Syst. Appl."},{"key":"18547_CR43","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1038\/nprot.2007.324","volume":"2","author":"MS Cline","year":"2007","unstructured":"Cline, M. S. et al. Integration of biological networks and gene expression data using Cytoscape. Nat. Protoc. 2, 2366\u20132382 (2007).","journal-title":"Nat. Protoc."},{"key":"18547_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"C-H Chin","year":"2014","unstructured":"Chin, C.-H. et al. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol. 8, 1\u20137 (2014).","journal-title":"BMC Syst. Biol."},{"key":"18547_CR45","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nmeth.2212","volume":"9","author":"R Saito","year":"2012","unstructured":"Saito, R. et al. A travel guide to Cytoscape plugins. Nat. Methods 9, 1069\u20131076 (2012).","journal-title":"Nat. Methods"},{"key":"18547_CR46","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/pro.3307","volume":"27","author":"PJ Thul","year":"2018","unstructured":"Thul, P. J. & Lindskog, C. The human protein atlas: a spatial map of the human proteome. Protein Sci. 27, 233\u2013244 (2018).","journal-title":"Protein Sci."},{"key":"18547_CR47","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/nar\/30.1.412","volume":"30","author":"X Chen","year":"2002","unstructured":"Chen, X., Ji, Z. L. & Chen, Y. Z. TTD: therapeutic target database. Nucleic Acids Res. 30, 412\u2013415 (2002).","journal-title":"Nucleic Acids Res."},{"key":"18547_CR48","first-page":"D335","volume":"48","author":"DR Armstrong","year":"2020","unstructured":"Armstrong, D. R. et al. PDBe: improved findability of macromolecular structure data in the PDB. Nucleic Acids Res. 48, D335\u2013D343 (2020).","journal-title":"Nucleic Acids Res."},{"key":"18547_CR49","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox, C. et al. Drugbank 6.0: the drugbank knowledgebase for 2024. Nucleic Acids Res. 52, D1265\u2013D1275 (2024).","journal-title":"Nucleic Acids Res."},{"key":"18547_CR50","doi-asserted-by":"crossref","unstructured":"Dallakyan, S. & Olson, A. J. Small-molecule library screening by docking with PyRx. Chemical biology: methods and protocols 243\u2013250 (2015).","DOI":"10.1007\/978-1-4939-2269-7_19"},{"key":"18547_CR51","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner, R. A. et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem. 47, 1739\u20131749 (2004).","journal-title":"J. Med. Chem."},{"key":"18547_CR52","first-page":"682","volume":"2020","author":"S Maestro","year":"2020","unstructured":"Maestro, S. Maestro. Schr\u00f6dinger, LLC, New York, NY 2020, 682 (2020).","journal-title":"Schr\u00f6dinger, LLC, New York, NY"},{"key":"18547_CR53","doi-asserted-by":"publisher","first-page":"125755","DOI":"10.1016\/j.molliq.2024.125755","volume":"411","author":"D-D Li","year":"2024","unstructured":"Li, D.-D., Ma, J.-R., Huang, Q.-R., Man, R.-J. & Zhao, L. Exploring protein-berberine interactions via molecular dynamics and MM\/GBSA calculations. J. Mol. Liq. 411, 125755 (2024).","journal-title":"J. Mol. Liq."},{"key":"18547_CR54","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/pro.3923","volume":"30","author":"BJ Grant","year":"2021","unstructured":"Grant, B. J., Skj\u00e6rven, L. & Yao, X. The Bio3D packages for structural bioinformatics. Protein Sci. 30, 20\u201330 (2021).","journal-title":"Protein Sci."},{"key":"18547_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17460441.2024.2349149","volume":"19","author":"VA Adediwura","year":"2024","unstructured":"Adediwura, V. A., Koirala, K., Do, H. N., Wang, J. & Miao, Y. Understanding the impact of binding free energy and kinetics calculations in modern drug discovery. Expert Opin. Drug Discov. 19, 1\u201312 (2024).","journal-title":"Expert Opin. Drug Discov."},{"key":"18547_CR56","doi-asserted-by":"publisher","first-page":"472a","DOI":"10.1016\/j.bpj.2023.11.2870","volume":"123","author":"M V\u00f6gele","year":"2024","unstructured":"V\u00f6gele, M., Zhang, B. W., Kaindl, J. & Wang, L. Is the functional response of a receptor determined by the thermodynamics of ligand binding?. Biophys J. 123, 472a (2024).","journal-title":"Biophys J."},{"key":"18547_CR57","doi-asserted-by":"publisher","first-page":"1409042","DOI":"10.3389\/fchem.2024.1409042","volume":"12","author":"M Imran","year":"2024","unstructured":"Imran, M. et al. Medicinal chemistry of active pharmaceutical ingredients of drug products. Front. Chem. 12, 1409042 (2024).","journal-title":"Front. Chem."},{"key":"18547_CR58","doi-asserted-by":"publisher","first-page":"W234","DOI":"10.1093\/nar\/gkz240","volume":"47","author":"G Zhou","year":"2019","unstructured":"Zhou, G. et al. NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res. 47, W234\u2013W241 (2019).","journal-title":"Nucleic Acids Res."},{"key":"18547_CR59","doi-asserted-by":"publisher","first-page":"D304","DOI":"10.1093\/nar\/gkad1071","volume":"52","author":"G Skoufos","year":"2024","unstructured":"Skoufos, G. et al. TarBase-v9. 0 extends experimentally supported miRNA\u2013gene interactions to cell-types and virally encoded miRNAs. Nucleic Acids Res. 52, D304\u2013D310 (2024).","journal-title":"Nucleic Acids Res."},{"key":"18547_CR60","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang, Z., Kang, B., Li, C., Chen, T. & Zhang, Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 47, W556\u2013W560 (2019).","journal-title":"Nucleic Acids Res."},{"key":"18547_CR61","doi-asserted-by":"publisher","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","volume":"52","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y. et al. TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 52, D1465\u2013D1477 (2024).","journal-title":"Nucleic Acids Res."},{"key":"18547_CR62","doi-asserted-by":"publisher","first-page":"101065","DOI":"10.1016\/j.jpha.2024.101065","volume":"15","author":"O Menyhart","year":"2024","unstructured":"Menyhart, O., Kothalawala, W. J. & Gy\u0151rffy, B. A gene set enrichment analysis for the cancer hallmarks. J Pharm Anal 15, 101065 (2024).","journal-title":"J Pharm Anal"},{"key":"18547_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-017-0179-x","volume":"7","author":"X Yan","year":"2017","unstructured":"Yan, X., Qi, M., Li, P., Zhan, Y. & Shao, H. Apigenin in cancer therapy: Anti-cancer effects and mechanisms of action. Cell Biosci. 7, 1\u201316 (2017).","journal-title":"Cell Biosci."},{"key":"18547_CR64","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.3390\/molecules27186051","volume":"27","author":"AH Rahmani","year":"2022","unstructured":"Rahmani, A. H. et al. The potential role of apigenin in cancer prevention and treatment. Molecules 27, 6051 (2022).","journal-title":"Molecules"},{"key":"18547_CR65","doi-asserted-by":"publisher","first-page":"5148","DOI":"10.1038\/s41598-019-41685-1","volume":"9","author":"S Koosha","year":"2019","unstructured":"Koosha, S., Mohamed, Z., Sinniah, A. & Alshawsh, M. A. Investigation into the molecular mechanisms underlying the anti-proliferative and anti-tumorigenesis activities of diosmetin against HCT-116 human colorectal cancer. Sci. Rep. 9, 5148 (2019).","journal-title":"Sci. Rep."},{"key":"18547_CR66","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.3390\/ijms20112734","volume":"20","author":"YH Lee","year":"2019","unstructured":"Lee, Y. H., Seo, E. K. & Lee, S.-T. Skullcapflavone II inhibits degradation of type I collagen by suppressing MMP-1 transcription in human skin fibroblasts. Int. J. Mol. Sci. 20, 2734 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"18547_CR67","doi-asserted-by":"publisher","first-page":"229","DOI":"10.5487\/TR.2013.29.4.229","volume":"29","author":"S-H Kim","year":"2013","unstructured":"Kim, S.-H. & Choi, K.-C. Anti-cancer effect and underlying mechanism (s) of kaempferol, a phytoestrogen, on the regulation of apoptosis in diverse cancer cell models. Toxicol. Res. 29, 229\u2013234 (2013).","journal-title":"Toxicol. Res."},{"key":"18547_CR68","doi-asserted-by":"publisher","first-page":"100912","DOI":"10.1039\/C5RA19199H","volume":"5","author":"LR Nath","year":"2015","unstructured":"Nath, L. R. et al. Kaempferide, the most active among the four flavonoids isolated and characterized from Chromolaena odorata, induces apoptosis in cervical cancer cells while being pharmacologically safe. RSC Adv. 5, 100912\u2013100922 (2015).","journal-title":"RSC Adv."},{"key":"18547_CR69","doi-asserted-by":"publisher","first-page":"111708","DOI":"10.1016\/j.fct.2020.111708","volume":"145","author":"S Singh","year":"2020","unstructured":"Singh, S., Gupta, P., Meena, A. & Luqman, S. Acacetin, a flavone with diverse therapeutic potential in cancer, inflammation, infections and other metabolic disorders. Food Chem. Toxicol. 145, 111708 (2020).","journal-title":"Food Chem. Toxicol."},{"key":"18547_CR70","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1038\/s41598-024-52896-6","volume":"14","author":"J Li","year":"2024","unstructured":"Li, J. et al. Acacetin inhibited non-small-cell lung cancer (NSCLC) cell growth via upregulating miR-34a in vitro and in vivo. Sci. Rep. 14, 2348 (2024).","journal-title":"Sci. Rep."},{"key":"18547_CR71","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3390\/ijms20030465","volume":"20","author":"J Gong","year":"2019","unstructured":"Gong, J., Zhou, S. & Yang, S. Vanillic acid suppresses HIF-1\u03b1 expression via inhibition of mTOR\/p70S6K\/4E-BP1 and Raf\/MEK\/ERK pathways in human colon cancer HCT116 cells. Int. J. Mol. Sci. 20, 465 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"18547_CR72","doi-asserted-by":"publisher","first-page":"109337","DOI":"10.1016\/j.cbi.2020.109337","volume":"337","author":"A Mihanfar","year":"2021","unstructured":"Mihanfar, A. et al. In vitro and in vivo anticancer effects of syringic acid on colorectal cancer: Possible mechanistic view. Chem. Biol. Interact. 337, 109337 (2021).","journal-title":"Chem. Biol. Interact."},{"key":"18547_CR73","doi-asserted-by":"publisher","first-page":"788929","DOI":"10.3389\/fnut.2021.788929","volume":"8","author":"J Pei","year":"2021","unstructured":"Pei, J., Velu, P., Zareian, M., Feng, Z. & Vijayalakshmi, A. Effects of syringic acid on apoptosis, inflammation, and AKT\/mTOR signaling pathway in gastric cancer cells. Front. Nutr. 8, 788929 (2021).","journal-title":"Front. Nutr."},{"key":"18547_CR74","doi-asserted-by":"publisher","first-page":"368","DOI":"10.35516\/jjps.v16i2.1463","volume":"16","author":"WH Ismail","year":"2023","unstructured":"Ismail, W. H. et al. Design, synthesis, and Biological Activity of Coniferyl Aldehyde Derivatives as potential anticancer and antioxidant agents. Jordan J. Pharmaceutical Sci. 16, 368\u2013380 (2023).","journal-title":"Jordan J. Pharmaceutical Sci."},{"key":"18547_CR75","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s00432-024-05648-y","volume":"150","author":"P Galiatsatos","year":"2024","unstructured":"Galiatsatos, P. et al. Psoralen: a narrative review of current and future therapeutic uses. J. Cancer Res. Clin. Oncol. 150, 130 (2024).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"18547_CR76","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.bmc.2016.12.025","volume":"25","author":"T Qwebani-Ogunleye","year":"2017","unstructured":"Qwebani-Ogunleye, T. et al. A one-pot laccase-catalysed synthesis of coumestan derivatives and their anticancer activity. Bioorg. Med. Chem. 25, 1172\u20131182 (2017).","journal-title":"Bioorg. Med. Chem."},{"key":"18547_CR77","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3390\/ijms18081667","volume":"18","author":"M-H Chien","year":"2017","unstructured":"Chien, M.-H. et al. Tricetin induces apoptosis of human leukemic HL-60 cells through a reactive oxygen species-mediated c-Jun N-terminal kinase activation pathway. Int. J. Mol. Sci. 18, 1667 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"18547_CR78","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1002\/tox.22380","volume":"32","author":"P Chang","year":"2017","unstructured":"Chang, P. et al. Tricetin inhibits human osteosarcoma cells metastasis by transcriptionally repressing MMP-9 via p38 and Akt pathways. Environ. Toxicol. 32, 2032\u20132040 (2017).","journal-title":"Environ. Toxicol."},{"key":"18547_CR79","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.2174\/156802607781696819","volume":"7","author":"GL Adrian","year":"2007","unstructured":"Adrian, G. L., Marcel, V., Robert, B. G. & Richard, T. A comparison of physicochemical property profiles of marketed oral drugs and orally bioavailable anti-cancer protein kinase inhibitors in clinical development. Curr. Top Med. Chem. 7, 1408\u20131422 (2007).","journal-title":"Curr. Top Med. Chem."},{"key":"18547_CR80","first-page":"21","volume":"28","author":"SQ Cai","year":"2006","unstructured":"Cai, S. Q., Chen, L. R. & Zheng, M. Effects of acitretin on the expression of signaling pathway-related genes in epidermal squamous-cell carcinoma cells. Zhonghua Zhong Liu Za Zhi 28, 21\u201324 (2006).","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"18547_CR81","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/d41573-021-00002-0","volume":"20","author":"A Mullard","year":"2021","unstructured":"Mullard, A. 2020 FDA drug approvals. Nat. Rev. Drug Discov. 20, 85\u201391 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"18547_CR82","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nrd2926","volume":"8","author":"P Liu","year":"2009","unstructured":"Liu, P., Cheng, H., Roberts, T. M. & Zhao, J. J. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat. Rev. Drug Discov. 8, 627\u2013644 (2009).","journal-title":"Nat. Rev. Drug Discov."},{"key":"18547_CR83","doi-asserted-by":"crossref","unstructured":"Mullard, A. 2014 FDA drug approvals. Nat Rev Drug Discov 14, (2015).","DOI":"10.1038\/nrd4545"},{"key":"18547_CR84","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1158\/0008-5472.CAN-18-2738","volume":"79","author":"M Song","year":"2019","unstructured":"Song, M., Bode, A. M., Dong, Z. & Lee, M.-H. AKT as a therapeutic target for cancer. Cancer Res. 79, 1019\u20131031 (2019).","journal-title":"Cancer Res."},{"key":"18547_CR85","doi-asserted-by":"publisher","first-page":"447","DOI":"10.5483\/BMBRep.2005.38.4.447","volume":"38","author":"S Stier","year":"2005","unstructured":"Stier, S. et al. Identification of p54 nrb and the 14-3-3 protein HS1 as TNF-\u03b1-inducible genes related to cell cycle control and apoptosis in human arterial endothelial cells. BMB Rep. 38, 447\u2013456 (2005).","journal-title":"BMB Rep."},{"key":"18547_CR86","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12943-023-01721-1","volume":"22","author":"M Bellon","year":"2023","unstructured":"Bellon, M. & Nicot, C. Targeting Pim kinases in hematological cancers: molecular and clinical review. Mol. Cancer 22, 18 (2023).","journal-title":"Mol. Cancer"},{"key":"18547_CR87","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1021\/acs.jmedchem.3c01802","volume":"67","author":"L Chen","year":"2024","unstructured":"Chen, L., Mao, W., Ren, C., Li, J. & Zhang, J. Comprehensive insights that targeting PIM for cancer therapy: prospects and obstacles. J. Med. Chem. 67, 38\u201364 (2024).","journal-title":"J. Med. Chem."},{"key":"18547_CR88","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/jac\/dkq429","volume":"66","author":"GA Denys","year":"2011","unstructured":"Denys, G. A., Grover, P., O\u2019Hanley, P. & Stephens, J. T. Jr. In vitro antibacterial activity of E-101 Solution, a novel myeloperoxidase-mediated antimicrobial, against gram-positive and gram-negative pathogens. J. Antimicrob. Chemother. 66, 335\u2013342 (2011).","journal-title":"J. Antimicrob. Chemother."},{"key":"18547_CR89","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3390\/ph17070889","volume":"17","author":"M Lorca","year":"2024","unstructured":"Lorca, M. et al. 2D\/3D-QSAR model development based on a Quinoline Pharmacophoric core for the inhibition of plasmodium falciparum: an in silico approach with experimental validation. Pharmaceuticals 17, 889 (2024).","journal-title":"Pharmaceuticals"},{"key":"18547_CR90","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/prca.201100104","volume":"6","author":"G Lochmanov\u00e1","year":"2012","unstructured":"Lochmanov\u00e1, G. et al. Potential biomarkers for early detection of acute graft-versus-host disease. PROTEOMICS-Clin. Appl. 6, 351\u2013363 (2012).","journal-title":"PROTEOMICS-Clin. Appl."},{"key":"18547_CR91","first-page":"4655","volume":"121","author":"F Ravandi","year":"2013","unstructured":"Ravandi, F. et al. Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutation. Blood, J. Am. Soc. Hematol. 121, 4655\u20134662 (2013).","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"18547_CR92","doi-asserted-by":"publisher","first-page":"ii104","DOI":"10.1136\/annrheumdis-2012-203037","volume":"72","author":"F Villanova","year":"2013","unstructured":"Villanova, F., Di Meglio, P. & Nestle, F. O. Biomarkers in psoriasis and psoriatic arthritis. Ann. Rheum Dis. 72, ii104\u2013ii110 (2013).","journal-title":"Ann. Rheum Dis."},{"key":"18547_CR93","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.bbi.2012.06.006","volume":"26","author":"NG Klimas","year":"2012","unstructured":"Klimas, N. G., Broderick, G. & Fletcher, M. A. Biomarkers for chronic fatigue. Brain Behav. Immun. 26, 1202\u20131210 (2012).","journal-title":"Brain Behav. Immun."},{"key":"18547_CR94","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.2174\/092986712800492968","volume":"19","author":"D Tousoulis","year":"2012","unstructured":"Tousoulis, D. et al. Predictive value of biomarkers in patients with heart failure. Curr. Med. Chem. 19, 2534\u20132547 (2012).","journal-title":"Curr. Med. Chem."},{"key":"18547_CR95","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.chest.2022.02.004","volume":"162","author":"J Spring","year":"2022","unstructured":"Spring, J. & Munshi, L. Hematology emergencies in adults with critical illness: malignant hematology. Chest 162, 120\u2013131 (2022).","journal-title":"Chest"},{"key":"18547_CR96","volume-title":"Seminars in Cancer Biology)","author":"P Gallipoli","year":"2018","unstructured":"Gallipoli, P. & Huntly, B. J. P. Novel epigenetic therapies in hematological malignancies: current status and beyond. In Seminars in Cancer Biology) (eds Gallipoli, P. & Huntly, B. J.) (Elsevier, 2018)."},{"key":"18547_CR97","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/tox.23400","volume":"37","author":"S Bhattacharyya","year":"2022","unstructured":"Bhattacharyya, S. & Law, S. Environmental pollutant N-N\u2032 ethylnitrosourea-induced leukemic NLRP3 inflammasome activation and its amelioration by Eclipta prostrata and its active compound wedelolactone. Environ. Toxicol. 37, 322\u2013334 (2022).","journal-title":"Environ. Toxicol."},{"key":"18547_CR98","first-page":"363","volume":"22","author":"K Lirdprapamongkol","year":"2008","unstructured":"Lirdprapamongkol, K. et al. Juice of Eclipta prostrata inhibits cell migration in vitro and exhibits anti-angiogenic activity in vivo. In Vivo (Brooklyn) 22, 363\u2013368 (2008).","journal-title":"In Vivo (Brooklyn)"},{"key":"18547_CR99","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1007\/s12272-015-0599-2","volume":"38","author":"H-Y Kim","year":"2015","unstructured":"Kim, H.-Y. et al. Constituents of the aerial parts of Eclipta prostrata and their cytotoxicity on human ovarian cancer cells in vitro. Arch. Pharm Res. 38, 1963\u20131969 (2015).","journal-title":"Arch. Pharm Res."},{"key":"18547_CR100","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1182\/blood.V126.23.570.570","volume":"126","author":"MM Cleary","year":"2015","unstructured":"Cleary, M. M. et al. Pacritinib, a dual FLT3\/JAK2 inhibitor, reduces IRAK-1 signaling in acute myeloid leukemia. Blood 126, 570 (2015).","journal-title":"Blood"},{"key":"18547_CR101","doi-asserted-by":"crossref","unstructured":"Mensah, A. A. et al. MEN1703\/SEL24, a potent PIM inhibitor, demonstrates promising anti-tumour activity in activated B cell like diffuse large B cell lymphoma, mantle cell lymphoma and marginal zone lymphoma cells. in MOLECULAR CANCER THERAPEUTICS vol. 22 (AMER ASSOC CANCER RESEARCH 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA\u00a0\u2026, 2023).","DOI":"10.1158\/1535-7163.TARG-23-C144"},{"key":"18547_CR102","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"key":"18547_CR103","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"18547_CR104","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41375-020-01069-1","volume":"35","author":"R Nair","year":"2021","unstructured":"Nair, R., Salinas-Illarena, A. & Baldauf, H.-M. New strategies to treat AML: novel insights into AML survival pathways and combination therapies. Leukemia 35, 299\u2013311 (2021).","journal-title":"Leukemia"},{"key":"18547_CR105","doi-asserted-by":"publisher","first-page":"634","DOI":"10.3390\/jcm4040634","volume":"4","author":"P Bose","year":"2015","unstructured":"Bose, P. & Grant, S. Rational combinations of targeted agents in AML. J. Clin. Med. 4, 634\u2013664 (2015).","journal-title":"J. Clin. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18547-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18547-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18547-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T12:03:55Z","timestamp":1758888235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18547-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["18547"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-18547-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33267"}}